logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
ddGTP
2',3'-Dideoxyguanosine-5'-triphosphate; 10 mM in ddH2O
Sanger sequencing, also known as the chain termination method, is a technique for DNA sequencing based upon the selective incorporation of chain-terminating dideoxynucleotides (ddNTPs) by DNA polymerase. It was developed by Frederick Sanger and colleagues in 1977. Although the newer NGS technologies are becoming common in clinical research labs due to their higher throughput capabilities and lower costs per sample, Sanger sequencing with 99.99% accuracy is still the “gold standard” for clinical research sequencing. dd-GTP is one of the four critical ddNTP components for performing Sanger sequencing.
Chemical structure for ddGTP [2',3'-Dideoxyguanosine-5'-triphosphate].
Chemical structure for ddGTP [2',3'-Dideoxyguanosine-5'-triphosphate].
CatalogSize
Price
Quantity
172101 umole
Price
 
Physical properties

Molecular weight491.18
SolventWater
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
StorageFreeze (< -15 °C); Minimize light exposure
UNSPSC12171501
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 27, 2025